An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

por Schulson, Lucy B., Dick, Andrew, Sheng, Flora, Stein, Bradley D.
Publicado 2023

Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention

por Stein, Bradley D., Landis, Rachel K., Sheng, Flora, Saloner, Brendan, Gordon, Adam J., Sorbero, Mark, Dick, Andrew W.
Publicado 2022

Changes in Nursing Home Use Following Medicaid-Supported Expanded Access to Home- and Community-Based Services for Older Adults With Dementia

por Harrison, Jordan M., Sheng, Flora, Josberger, Raina E., Liu, Harry H., Stone, Patricia W., Luchsinger, José A., Dick, Andrew W.
Publicado 2023

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018

por Golan, Olivia K., Sheng, Flora, Dick, Andrew W., Sorbero, Mark, Whitaker, Daniel J., Andraka-Christou, Barbara, Pigott, Therese, Gordon, Adam J., Stein, Bradley D.
Publicado 2023

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

por Stein, Bradley D., Saloner, Brendan K., Golan, Olivia K., Andraka-Christou, Barbara, Andrews, Christina M., Dick, Andrew W., Davis, Corey S., Sheng, Flora, Gordon, Adam J.
Publicado 2023